[ad_1]
Al-Arabiya television reported on Thursday a report on the production of a new drug against cancer.
The FDA has approved this drug, which targets cancer cells early on in its genetic makeup, noting that the drug has been approved by the relevant US authorities and called it "Vitrakvi".
The report states that the drug prevents the spread of cancer cells, regardless of their type or place of origin, and that it has been adopted after a large number of experiments including the disease and registered the state of recovery of a child after a few months.
For his part, Dr. Fahad al-Khudairy, a researcher and consultant in the treatment of cancer, said the drug would change the treatment methods to 100%.
According to the report, according to the manufacturers of the new drug will be presented in the form of tablets or capsules, or in the form of drug syrup for children in particular.
[ad_2]
Source link
